Baseline obesity is associated with an increased risk for late-life mobility limitations in women undergoing joint replacement for OA.
Risedronate could significantly reduce periprosthetic bone resorption in patients undergoing total hip arthroplasty.
A set of psychosocial and sociodemographic factors may be associated with pain levels in patients with knee osteoarthritis.
In 2014, healthcare provider counseling for weight loss for adults with arthritis and overweight or obesity was 45.5%, which increased from 10.4% in 2002.
The risk for myocardial infarction in patients with spondyloarthritis is increased in patients taking diclofenac, but not in patients taking naproxen.
Interim data have been released from a phase 3b, open-label study that evaluated the safety and tolerability of repeat administration of Zilretta in patients with knee osteoarthritis.
Men, non-Hispanic blacks, and participants with low income or obesity had the most pronounced decrease in RA prevalence.
Researchers sought to determine the predictive value of tibiofemoral MRI, patellofemoral MRI, and KLG1 for the incidence of clinical or radiographic knee OA.
The randomized, double-blind, controlled trial (N=24,081) included patients with rheumatoid arthritis or osteoarthritis who required chronic NSAID treatment.
In patients with painful hip osteoarthritis, an intramuscular glucocorticoid injection may effectively alleviate hip pain in the short-term.